These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14500049)

  • 1. A matter of life and death? The Heart Protection Study and protection of clinical trial participants.
    Migrino RQ; Topol EJ;
    Control Clin Trials; 2003 Oct; 24(5):501-5. PubMed ID: 14500049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
    Collins R; Armitage J; Parish S; Sleight P; Peto R;
    Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
    Pedersen TR
    Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
    Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J;
    Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-based rehabilitation for coronary heart disease.
    Jolliffe JA; Rees K; Taylor RS; Thompson D; Oldridge N; Ebrahim S
    Cochrane Database Syst Rev; 2000; (4):CD001800. PubMed ID: 11034729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
    Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
    Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial.
    Papazian L; Roch A; Charles PE; Penot-Ragon C; Perrin G; Roulier P; Goutorbe P; Lefrant JY; Wiramus S; Jung B; Perbet S; Hernu R; Nau A; Baldesi O; Allardet-Servent J; Baumstarck K; Jouve E; Moussa M; Hraiech S; Guervilly C; Forel JM;
    JAMA; 2013 Oct; 310(16):1692-700. PubMed ID: 24108510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).
    Miettinen TA; Pyörälä K; Olsson AG; Musliner TA; Cook TJ; Faergeman O; Berg K; Pedersen T; Kjekshus J
    Circulation; 1997 Dec; 96(12):4211-8. PubMed ID: 9416884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins.
    Prescrire Int; 2003 Aug; 12(66):143-8. PubMed ID: 12908497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atherosclerosis and simvastatin: new questions for the new millennium].
    Tubaro M; Guido V; Sciarra L; Mustilli M; Carbone MA; D'Errico F
    Ann Ital Med Int; 2000; 15(1):108-14. PubMed ID: 10842900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
    Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J
    Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
    Haffner SM; Alexander CM; Cook TJ; Boccuzzi SJ; Musliner TA; Pedersen TR; Kjekshus J; Pyörälä K
    Arch Intern Med; 1999 Dec 13-27; 159(22):2661-7. PubMed ID: 10597756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
    Kjekshus J; Pedersen TR
    Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of the month. The MRC/BHF Heart Protection Study].
    Kulbertus H; Scheen AJ
    Rev Med Liege; 2002 Sep; 57(9):613-6. PubMed ID: 12440352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.
    Pedersen TR; Kjekshus J; Berg K; Olsson AG; Wilhelmsen L; Wedel H; Pyörälä K; Miettinen T; Haghfelt T; Faergeman O; Thorgeirsson G; Jönsson B; Schwartz JS
    Circulation; 1996 May; 93(10):1796-802. PubMed ID: 8635258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.